Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE(®) system

OBJECTIVES: Cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) are well‐established in research settings, but their use in routine clinical practice remains a largely unexploited potential. Here, we examined the relationship between CSF biomarkers, measured by a fully automated im...

Descripción completa

Detalles Bibliográficos
Autores principales: Nojima, Hisashi, Ito, Satoshi, Kushida, Akira, Abe, Aki, Motsuchi, Wataru, Verbel, David, Vandijck, Manu, Jannes, Geert, Vandenbroucke, Ina, Aoyagi, Katsumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735374/
https://www.ncbi.nlm.nih.gov/pubmed/36321325
http://dx.doi.org/10.1002/acn3.51681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735374/
https://www.ncbi.nlm.nih.gov/pubmed/36321325
http://dx.doi.org/10.1002/acn3.51681

Ejemplares similares